Markets:

Overview

News

Currencies

International

Treasuries

NanoViricides, Inc. Common Stock (NY:NNVC)

0.9263 -0.0299 (-3.13%)

Official Closing Price Updated: 8:00 PM EST, Mar 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about NanoViricides, Inc. Common Stock

< Previous 1 2 3 4 Next >

NanoViricides Inc. (NYSE American: NNVC) Begins Long-Awaited Clinical Trials For Its Anti-Viral Nanomedicine NV-CoV-2, Oral, Amid Continuing Need For COVID Treatment ↗

July 05, 2023

Read the latest report on NanoViricides here.

Via Benzinga

The 7 Most Promising Penny Stocks to Buy in June ↗

June 07, 2023

These top penny stocks for June look to have legitimate catalysts that can certainly send share prices higher.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

June 02, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

June 01, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 07, 2023

Via Benzinga

Short Volatility Alert: NanoViricides, Inc. ↗

August 05, 2022

On Thursday, shares of NanoViricides, Inc. (NYSE: NNVC) experienced volatile short activity. After the activity, the stock price went up +48.37% to $3.65. The overall sentiment for NNVC has been...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 06, 2023

Via Benzinga

COVID Remains A Global Threat – NanoViricides Set To Begin Clinical Trials For Pan-Coronavirus Drug To Help Defeat COVID Once And For All

March 31, 2023

COVID Remains A Global Threat – NanoViricides Set To Begin Clinical Trials For Pan-Coronavirus Drug To Help Defeat COVID Once And For All

Via News Direct

A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats

March 20, 2023

A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats

Via News Direct

Topics Death Economy

With Nearly 20,000 Americans Still Hospitalized, COVID Remains A Threat – NanoViricides Gets Ready To Begin Clinical Trials For The World To Defeat It

March 08, 2023

With Nearly 20,000 Americans Still Hospitalized, COVID Remains A Threat – NanoViricides Gets Ready To Begin Clinical Trials For The World To Defeat It

Via News Direct

Topics Death

With Nearly 20,000 Americans Still Hospitalized, COVID Remains A Threat – NanoViricides Gets Ready To Begin Clinical Trials For The World To Defeat It, And To Prepare For Battling Against The Next Likely Coronavirus Pandemic ↗

March 08, 2023

Read the latest report on NanoViricides, Inc (NYSE: NNVC) here.

Via Benzinga

uniQure To Rally Around 162%? Here Are 10 Other Analyst Forecasts For Tuesday ↗

February 28, 2023

UBS cut the price target for Honeywell International Inc. (NASDAQ: HON) from $193 to $185. UBS analyst Chris Snyder maintained a Sell rating. Honeywell shares fell 0.2% to $191.99 in pre-market...

Via Benzinga

7 Speculative Penny Stocks Under $3 That Deserve Your Attention in Nov. ↗

October 28, 2022

While penny stocks are highly speculative and risky, you may still want to consider these seven opportunities.

Via InvestorPlace

This Company Is Looking For A Monkeypox Drug As City Investigates Deaths

October 27, 2022

By David Willey, Benzinga

Via News Direct

Topics Death

This Company Is Looking For A Monkeypox Drug As City Investigates Deaths ↗

October 27, 2022

New York City is investigating the cause of death for two people who died after contracting monkeypox.

Via Benzinga

NanoViricides Reports Its Novel Monkeypox Antiviral Could Reach Clinical Status Rapidly

September 19, 2022

By Rachael Green, Benzinga

Via News Direct

Monkeypox Is Popping Up In Places It Shouldn't But NanoViricides Says It May Have A Solution ↗

August 10, 2022

More than 30,000 confirmed or suspected cases of monkeypox have been reported across 93 countries in the world. While those numbers are still small scientists are now concerned that this sudden and...

Via Benzinga

NanoViricides Initiates New Drug Development To Combat Monkeypox Virus ↗

August 05, 2022

NanoViricides, Inc. (NYSE American: NNVC) reports that it has begun drug development to combat the monkeypox virus.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

August 04, 2022

Good morning! It's time for another dive into the biggest pre-market stock movers as we see what's affecting shares on Thursday!

Via InvestorPlace

NanoViricides Patents Its Antiviral Nanotechnology for COVID-19, Continuing Its Development of Potentially Broad-Spectrum Drugs That Are Expected To Be Effective Even Against Emerging Variants ↗

May 25, 2022

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Via Benzinga

Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday ↗

August 05, 2022

Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share...

Via Benzinga

Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session ↗

August 04, 2022

Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday.

Via Benzinga

58 Biggest Movers From Yesterday ↗

May 24, 2022

Gainers Catalyst Biosciences, Inc. (NASDAQ: CBIO) gained 234.2% to close at $1.27 after the company announced it sold its complement portfolio for $60 million.

Via Benzinga

30 Stocks Moving In Monday's Mid-Day Session ↗

May 23, 2022

Gainers Evolve Transition Infrastructure LP (NYSE: SNMP) shares rose 29.2% to $0.6699 after jumping around 14% on Friday.

Via Benzinga

Mid-Morning Market Update: Markets Mixed; Broadcom In Talks To Buy VMWare ↗

May 23, 2022

U.S. stocks traded mixed this morning, with the Dow Jones gaining around 250 points on Monday.

Via Benzinga

24 Stocks Moving in Monday's Pre-Market Session ↗

May 23, 2022

Gainers Genocea Biosciences, Inc. (NASDAQ: GNCA) shares rose 33.8% to $0.2795 in pre-market trading after declining around 5% on Friday.

Via Benzinga

The Week Ahead In Biotech (May 22-28): Verrica, Bristol-Myers Squibb FDA Decisions, Medtronic Earnings, Conference Presentations & More ↗

May 22, 2022

Biotech stocks advanced in the week ending May 22, defying the broader market retreat. The defensive nature of the industry and stock-specific moves lent support.

Via Benzinga

66 Biggest Movers From Friday ↗

May 23, 2022

Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) shares surged 90.2% to settle at $1.39 on Friday. GeoVax Labs, last month, said its Q1 sales results were lower year over year.

Via Benzinga

CDC Looking Into 180 Cases Of Unexplained Pediatric Acute Hepatitis: CNBC ↗

May 19, 2022

The Centers for Disease Control and Prevention is now investigating 180 cases of children who suddenly developed severe hepatitis across 36 states and territories, an increase of 71 cases since the...

Via Benzinga

71 Biggest Movers From Yesterday ↗

May 20, 2022

Gainers NeuroMetrix, Inc. (NASDAQ: NURO) shares jumped 76.3% to close at $5.50 on Thursday after the company announced the FDA has granted De Novo authorization to market the Quell neuromodulation...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.